Panelists discuss how prescription digital therapeutics differ from traditional pharmaceuticals by following FDA medical ...

Panelists discuss how combination trials like VIALE-A and VIALE-C have demonstrated venetoclax’s survival benefits when added ...

Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and ...

MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...

AI is revolutionizing healthcare by improving diagnostics, reducing clinician workload, and enhancing care access, ...

Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...

Experts discuss the importance of safe, effective topical therapies for long-term management of atopic dermatitis, ...

Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies ...

Expanding PrEP access through pharmacies could improve uptake, especially in high HIV caseload areas, due to their greater availability compared to PrEP-prescribing facilities. The study used geocoded ...

Oral HIV pre-exposure prophylaxis (PrEP) adoption varies across the US, with posters presented at the Academy of Managed Care Pharmacy Nexus 2025 meeting in National Harbor, Maryland, highlighting ...

In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...

Texas AG Ken Paxton accuses J&J and Kenvue of deceptive marketing of acetaminophen as safe during pregnancy, alleging concealed risks to fetal development. The lawsuit cites violations of Texas ...